PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROSSAN JOSE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts. Management is scheduled to present on Wednesday, September 4 at 1:30 p.m. Eastern Time.
加利福尼亞州聖何塞，2024年8月28日（環球新聞社） - 科普博機器人（納斯達克：PRCT）（「公司」）是一家專注於推動泌尿科患者護理的外科機器人公司，致力於通過開發變革性的解決方案在泌尿外科領域取得進展。今天宣佈，公司管理層將在位於馬薩諸塞州波士頓舉行的2024年富國銀行醫療保健大會上發表演講。管理層計劃於9月4日星期三下午1:30東部時間發表演講。
A live webcast of each event, as well as an archived recording, will be available on the "Investors" section of the company's website at: . The webcasts will be archived and available for replay for at least 90 days after the event.
公司網站的「投資者」部分將提供每個活動的現場網絡廣播以及存檔記錄：webcasts將存檔，並在活動之後的至少90天內提供重播。
About PROCEPT BioRobotics Corporation
關於PROCEPT BioRobotics公司
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The HYDROSTM Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
科普博機器人是一家專注於推動泌尿科患者護理的外科機器人公司，通過開發變革性的解決方案來實現目標。HYDROSTm機器人系統是唯一的人工智能驅動的機器人技術，提供水切療法。科普博機器人設計出水切療法，以提供對因良性前列腺增生症導致的下尿路症狀或LUTS的男性而言有效、安全且持久的療效，而這些因素與前列腺大小和形狀或外科醫生的經驗無關。BPH是最常見的前列腺疾病，影響着美國約4000萬男性。公司已經積累了大量且不斷增長的臨床證據，有150多篇同行評議的出版物，支持水切療法的益處和臨床優勢。
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@procept-biorobotics.com
投資者聯繫人：
Matt Bacso
副總裁，投資者關係和業務運營
m.bacso@procept-biorobotics.com
譯文內容由第三人軟體翻譯。